Monthly Lectures | Third Wednesdays | Hybrid
The Henry Ford + MSU Distinguished Cancer Research Lecture Series aims to highlight exciting, cutting-edge cancer research, generate new ideas, and build new collaborations among Henry Ford Health, Michigan State University, and researchers at other cancer centers.
Faculty members, research staff, graduate/medical students, and health care professionals are invited to join this seminar series. Lectures will be on the third Wednesday of every month from noon to 1 p.m. (EST/EDT), alternating between the Henry Ford Health campus in Detroit and the Michigan State University campus in East Lansing. Lunch will be provided for in-person attendees.
No registration is required to participate in the Henry Ford + MSU Distinguished Cancer Research Lecture Series.
Locations
| Interdisciplinary Science Technology Building Room 1404 766 Service Rd East Lansing, MI | Henry Ford Hospital Room ER2096 2799 W Grand Blvd Detroit, MI |
Questions
For any questions, please contact Henry Ford + MSU Cancer Project Coordinator Jenna Anheuser, janheus3@hfhs.org.
Lectures
Lecture Topic
Normalization of Cancer Associated Fibroblast Pro-tumor Functions as a Therapeutic Opportunity in Pancreatic Cancer
About the Speakers
Ralph Francescone, Ph.D., and Débora Vendramini Costa, Ph.D., co-lead the Vendramini-Francescone Lab at Henry Ford Health and hold research faculty appointments at Michigan State University. Their work seeks to understand how the tumor microenvironment shapes pancreatic cancer development, immune suppression, and response to treatment. By integrating innovative laboratory models with patient-derived samples, they are uncovering new opportunities for early detection and therapeutic intervention. Together, they lead nationally funded research programs focused on improving outcomes for patients with pancreatic cancer
Learn More About Henry Ford + MSU Cancer Efforts